Literature DB >> 3100431

Multiple biological properties of recombinant human interleukin 1 (beta).

C A Dinarello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100431     DOI: 10.1016/S0171-2985(86)80112-7

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


× No keyword cloud information.
  15 in total

1.  Modulation of voltage-activated ion currents on identified neurons of Helix pomatia L. by interleukin-1.

Authors:  A Szûcs; G B Stefano; T K Hughes; K S Rózsa
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

2.  Pathophysiologic effect of interleukin-1b in the rabbit retina.

Authors:  J A Martiney; M Litwak; J W Berman; J C Arezzo; C F Brosnan
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.

Authors:  C Ucla; P Roux-Lombard; S Fey; J M Dayer; B Mach
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation.

Authors:  Erez Dror; Elise Dalmas; Daniel T Meier; Stephan Wueest; Julien Thévenet; Constanze Thienel; Katharina Timper; Thierry M Nordmann; Shuyang Traub; Friederike Schulze; Flurin Item; David Vallois; Francois Pattou; Julie Kerr-Conte; Vanessa Lavallard; Thierry Berney; Bernard Thorens; Daniel Konrad; Marianne Böni-Schnetzler; Marc Y Donath
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

5.  Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2.

Authors:  S M Hsu; K Krupen; L B Lachman
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

6.  A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma.

Authors:  A Lindemann; K Höffken; R E Schmidt; V Diehl; O Kloke; H Gamm; J Hayungs; W Oster; M Böhm; J E Kolitz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 7.  Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease.

Authors:  Marc Y Donath; Daniel T Meier; Marianne Böni-Schnetzler
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

8.  Thrombin and factor Xa enhance the production of interleukin-1.

Authors:  A Jones; C L Geczy
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

9.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

10.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.